文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

稳态迁移的 RelB+ langerin+ 真皮树突状细胞介导外周诱导抗原特异性 CD4+ CD25+ Foxp3+ 调节性 T 细胞。

Steady state migratory RelB+ langerin+ dermal dendritic cells mediate peripheral induction of antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells.

机构信息

Department of Dermatology, University Hospital Erlangen, Erlangen, Germany.

出版信息

Eur J Immunol. 2011 May;41(5):1420-34. doi: 10.1002/eji.201040930. Epub 2011 Apr 14.


DOI:10.1002/eji.201040930
PMID:21469094
Abstract

Tolerance to self-antigens expressed in peripheral organs is maintained by CD4(+) CD25(+) Foxp3(+) Treg cells, which are generated as a result of thymic selection or peripheral induction. Here, we demonstrate that steady-state migratory DCs from the skin mediated Treg conversion in draining lymph nodes of mice. These DCs displayed a partially mature MHC II(int) CD86(int) CD40(hi) CCR7(+) phenotype, used endogenous TGF-β for conversion and showed nuclear RelB translocation. Deficiency of the alternative NF-κB signaling pathway (RelB/p52) reduced steady-state migration of DCs. These DCs transported and directly presented soluble OVA provided by s.c. implanted osmotic minipumps, as well as cell-associated epidermal OVA in transgenic K5-mOVA mice to CD4(+) OVA-specific TCR-transgenic OT-II T cells. The langerin(+) dermal DC subset, but not epidermal Langerhans cells, mediated conversion of naive OT-II×RAG-1(-/-) T cells into proliferating CD4(+) CD25(+) Foxp3(+) Tregs. Thus, our data suggest that steady-state migratory RelB(+) TGF-β(+) langerin(+) dermal DCs mediate peripheral Treg conversion in response to epidermal antigen in skin-draining lymph nodes.

摘要

外周器官中表达的自身抗原的耐受性由 CD4(+) CD25(+) Foxp3(+) Treg 细胞维持,这些细胞是由于胸腺选择或外周诱导而产生的。在这里,我们证明了来自皮肤的稳态迁移 DC 可在小鼠引流淋巴结中介导 Treg 转化。这些 DC 表现出部分成熟的 MHC II(int) CD86(int) CD40(hi) CCR7(+)表型,利用内源性 TGF-β 进行转化,并显示核 RelB 易位。替代 NF-κB 信号通路(RelB/p52)的缺陷减少了 DC 的稳态迁移。这些 DC 运输并直接呈递由皮下植入的渗透微型泵提供的可溶性 OVA,以及转基因 K5-mOVA 小鼠中的细胞相关表皮 OVA,以向 CD4(+) OVA 特异性 TCR 转基因 OT-II T 细胞呈递。朗格汉斯细胞(+)真皮 DC 亚群,而不是表皮朗格汉斯细胞,介导幼稚 OT-II×RAG-1(-/-) T 细胞向增殖的 CD4(+) CD25(+) Foxp3(+) Treg 的转化。因此,我们的数据表明,稳态迁移的 RelB(+) TGF-β(+) langerin(+)真皮 DC 可介导外周 Treg 转化,以响应皮肤引流淋巴结中的表皮抗原。

相似文献

[1]
Steady state migratory RelB+ langerin+ dermal dendritic cells mediate peripheral induction of antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells.

Eur J Immunol. 2011-4-14

[2]
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

J Exp Med. 2003-12-15

[3]
Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.

J Immunol. 2010-9-24

[4]
Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.

Scand J Immunol. 2006-9

[5]
Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.

Int Immunol. 2007-3

[6]
Lack of retinoic acid leads to increased langerin-expressing dendritic cells in gut-associated lymphoid tissues.

Gastroenterology. 2009-11-13

[7]
Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.

Immunol Lett. 2009-8-15

[8]
Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.

Gastroenterology. 2007-8

[9]
Dendritic cells and B cells cooperate in the generation of CD4(+)CD25(+)FOXP3(+) allogeneic T cells.

Transplant Proc. 2010

[10]
TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.

J Leukoc Biol. 2007-8

引用本文的文献

[1]
Dominant immune tolerance in the intestinal tract imposed by RelB-dependent migratory dendritic cells regulates protective type 2 immunity.

Nat Commun. 2024-10-23

[2]
Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis.

J Neuroinflammation. 2022-12-12

[3]
Transcriptional programming of immunoregulatory responses in human Langerhans cells.

Front Immunol. 2022

[4]
Obesity aggravates contact hypersensitivity reaction in mice.

Contact Dermatitis. 2022-7

[5]
Applications of Antibody-Based Antigen Delivery Targeted to Dendritic Cells In Vivo.

Antibodies (Basel). 2022-1-25

[6]
Variegated Outcomes of T Cell Activation by Dendritic Cells in the Steady State.

J Immunol. 2022-2-1

[7]
In Vivo Expansion of Antigen-Specific Regulatory T Cells through Staggered Fc.IL-2 Mutein Dosing and Antigen-Specific Immunotherapy.

Immunohorizons. 2021-9-28

[8]
Conversion of Anergic T Cells Into Foxp3 IL-10 Regulatory T Cells by a Second Antigen Stimulus .

Front Immunol. 2021

[9]
Fate mapping analysis reveals a novel murine dermal migratory Langerhans-like cell population.

Elife. 2021-3-26

[10]
Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance.

Front Immunol. 2021

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索